Production (Stage)
DermTech, Inc.
DMTKQ
$0.00
$0.000.00%
OTC PK
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Net Income | 23.94% | 13.54% | 3.92% | -13.01% | -26.21% |
Total Depreciation and Amortization | 4.75% | 31.08% | 61.41% | 79.96% | 104.30% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -18.84% | -7.52% | 12.75% | 33.95% | 24.92% |
Change in Net Operating Assets | -1,049.16% | 100.43% | 53.59% | 112.09% | 135.79% |
Cash from Operations | 22.06% | 19.19% | 11.59% | -3.93% | -21.32% |
Capital Expenditure | 95.76% | 72.71% | -23.48% | 5.58% | -1.85% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 3,043.54% | 3,134.12% | 342.72% | 166.55% | 90.51% |
Cash from Investing | 1,021.53% | 791.46% | 270.91% | 140.68% | 74.89% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 19.33% | 16.79% | 36.92% | 25.28% | 35.33% |
Issuance of Common Stock | 279.86% | 487.57% | 429.32% | 249.50% | -94.46% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 304.67% | 562.92% | 522.56% | 281.82% | -94.88% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 78.27% | 58.41% | 46.10% | 26.71% | -36.33% |